LGV (Lymphogranuloma Venereum) — The Rising MSM STI

LGV (lymphogranuloma venereum) is caused by specific serovars of Chlamydia trachomatis (L1, L2, L3) — distinct from the strains causing typical chlamydia. It causes severe rectal disease, especially in MSM (men who have sex with men), and has been rising in US/European outbreaks since the 2000s.

LGV requires longer treatment than standard chlamydia. Misdiagnosis as inflammatory bowel disease (IBD) is common. Here's the practical picture.

The short answer

  • What it is: Chlamydia trachomatis L-serotype infection
  • Main population affected: MSM, particularly HIV+ MSM with high partner counts
  • Main presentation: Severe rectal inflammation (proctocolitis) with rectal pain, discharge, bleeding, fever
  • Diagnosis: Rectal swab → chlamydia NAAT → genotype testing for L-serovar (when LGV suspected)
  • Treatment: Doxycycline 100 mg twice daily for 21 days (NOT the 7 days for standard chlamydia)
  • Misdiagnosis: Often confused with IBD or cancer; can lead to unnecessary procedures

What LGV looks like

Stage 1: Primary lesion (often missed)

  • Small painless ulcer or papule at site of infection
  • Typically at rectum, genitals, or oral mucosa
  • Resolves on its own in days to weeks
  • Often not recognized as STI

Stage 2: Lymph node involvement

  • "Buboes" — swollen, sometimes tender lymph nodes
  • Inguinal (groin) area most common for genital LGV
  • Less common in rectal LGV

Stage 3: Rectal LGV (most common presentation in MSM)

  • Proctocolitis: rectum and colon inflammation
  • Severe rectal pain
  • Bloody or mucous rectal discharge
  • Sensation of needing to defecate (tenesmus)
  • Constipation alternating with diarrhea
  • Sometimes fever
  • Sometimes anal/perianal ulcers
  • Lymph node swelling around rectum (palpable on exam)

Late complications (untreated)

  • Rectal strictures
  • Fistulas
  • Permanent lymph node damage
  • Chronic pain

Who's at risk

High-risk groups

  • MSM with multiple recent partners — primary risk
  • HIV+ MSM — significantly elevated risk
  • Those engaging in receptive anal sex with multiple partners
  • Travelers to areas with LGV outbreaks (Europe, US major cities)

Lower risk

  • Women — less commonly affected
  • Heterosexual men — rare

Why it's often misdiagnosed

LGV proctocolitis can look exactly like:

  • Inflammatory bowel disease (IBD) — Crohn's or ulcerative colitis
  • Rectal cancer
  • Other infectious proctocolitis (gonorrhea, herpes, syphilis)

Patients sometimes go through:

  • Colonoscopy with biopsy
  • IBD diagnosis and treatment
  • Months of immunosuppression
  • Worsening symptoms
  • Finally getting LGV diagnosis

This is why testing for LGV in MSM with rectal symptoms is so important.

How LGV is tested

Step 1: Standard chlamydia NAAT

  • Rectal swab → tests for chlamydia
  • Positive for chlamydia → could be standard strain or LGV

Step 2: LGV genotyping

  • Sample sent to specialty lab
  • Determines if L-serovar is present
  • Not always done routinely — must be specifically requested

When to specifically request LGV testing

  • Severe rectal symptoms (proctocolitis)
  • Rectal chlamydia positive in MSM with symptoms
  • Inguinal lymphadenopathy in genital infection
  • Symptoms not responding to standard chlamydia treatment
  • High clinical suspicion in high-risk population

Treatment

Standard regimen

  • Doxycycline 100 mg twice daily for 21 days
  • 21 days — significantly longer than standard chlamydia (7 days)
  • Treatment must complete the full course

Alternative regimens

  • Azithromycin 1 g weekly for 3 weeks — if doxycycline can't be used
  • Erythromycin 500 mg four times daily for 21 days

In pregnancy

  • Erythromycin 500 mg four times daily for 21 days (doxycycline is contraindicated)
  • Azithromycin 1 g weekly for 3 weeks may be alternative

Failure rates

  • ~5-10% of cases don't respond to first-line treatment
  • Re-evaluation, longer course, or alternative antibiotics for persistence
  • Specialty consultation if standard treatment fails

After treatment

  • Test of cure NOT routinely needed unless symptoms persist
  • Partners need treatment — all sexual contacts from past 60 days
  • Avoid sex for 7 days after starting treatment
  • Re-test at 3 months for reinfection
  • HIV testing strongly recommended at diagnosis if not recent

Partner notification

  • All sexual partners from past 60 days should be tested AND treated
  • "Expedited partner therapy" sometimes appropriate but often complex for LGV (longer regimen)
  • HIV status of partner(s) also relevant

LGV in 2026 — the epidemiology

  • Outbreaks in major US cities continued through 2010s and 2020s
  • Predominantly in MSM
  • Often co-infection with HIV (50-80% in some cohorts)
  • DoxyPEP (used for general bacterial STI prevention) may reduce LGV incidence — see doxyPEP
  • Public health surveillance continues; LGV reportable in many jurisdictions

Prevention

Same as for general STIs

  • Condom use during anal sex
  • Partner discussions and disclosure
  • Routine STI screening
  • HIV PrEP (for HIV-negative MSM)
  • DoxyPEP for eligible MSM

Specific to LGV

  • Awareness in high-risk populations
  • Prompt evaluation of rectal symptoms
  • Avoid sharing sex toys without cleaning
  • Avoid fisting / extensive rectal contact during peak outbreak periods

Differential diagnosis

If you have rectal symptoms, the differential includes:

  • LGV proctocolitis
  • Standard chlamydia proctitis
  • Gonorrhea proctitis
  • Herpes proctitis
  • Syphilis (anorectal chancre)
  • Inflammatory bowel disease (Crohn's, ulcerative colitis)
  • Rectal cancer
  • Anal fissure
  • Hemorrhoids with infection
  • Trauma (e.g., from anal sex)

Proper evaluation includes:

  • Rectal swab for chlamydia/gonorrhea NAAT
  • HSV and syphilis testing if ulcers
  • Visual examination
  • Sometimes flexible sigmoidoscopy for severe symptoms

What to ask your provider

"Can you specifically test for LGV? I have rectal symptoms and I'm in a higher-risk group."

"If positive, will I get the 21-day course?"

"What's the protocol for partner notification?"

"Am I a candidate for doxyPEP or PrEP going forward?"

Common misconceptions

"LGV is rare and exotic — I don't need to worry." Outbreaks have been ongoing in major US/European cities for 20 years. If you're MSM with rectal symptoms, ask.

"Chlamydia treatment will cover it." Standard 7-day treatment is insufficient for LGV. 21 days is needed.

"I don't have symptoms — I'm fine." Asymptomatic LGV is possible, especially in early stages. Routine extragenital STI screening matters.

"LGV is just severe chlamydia." It's a distinct entity with longer treatment, different complications, and different epidemiology.

Bottom line

LGV is:

  • A serious form of chlamydia affecting mostly MSM
  • Causes severe rectal inflammation that can mimic IBD or cancer
  • Diagnosed with rectal NAAT + LGV genotyping (must be specifically requested)
  • Treated with 21 days of doxycycline (NOT 7)
  • Reportable in many jurisdictions
  • Worth specifically requesting testing for if you're MSM with rectal symptoms

If you're MSM and have severe rectal symptoms — discharge, bleeding, pain, fever — make sure LGV is on your provider's radar. The earlier it's identified, the easier it is to treat. Untreated, it can cause permanent complications.


For related content, see gonorrhea treatment + antibiotic resistance, chlamydia symptoms in men, doxyPEP, and asymptomatic throat gonorrhea.